Skip to main content
SpringerLink
Log in

New adverse cardiovascular events have been identified from the RE-LY* trial after a review of study data

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Connolly SJ, Ezekowitz MD, Yusuf S, Reilly PA, Wallentin L.Newly identified events in the RE-LY trial. New England Journal of Medicine 363: 1875-6, No. 19, 4 Nov 2010. Available from: URL: http://dx.doi.org/10.1056/nejmc1007378

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

New adverse cardiovascular events have been identified from the RE-LY* trial after a review of study data. React. Wkly. 1329, 2 (2010). https://doi.org/10.2165/00128415-201013290-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013290-00004

Keywords

Search

Navigation